Ricevi le ultime notizie sulle azioni SIGA Technologies con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di SIGA

Ultime notizie per

SIGA Technologies

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

SIGA Technologies Inc

Health Care

Press Releases

General

Interim Results from STOMP Study of SIGA's Tecovirimat in Treatment of Mpox Announced

TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

News

SIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full Year 2024 Financial Results

Earnings

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024

Management

SIGA Appoints Retired General John M. Keane to its Board of Directors

Dividends

SIGA Declares Special Cash Dividend of $0.60 Per Share

SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results

SIGA Reports Financial Results for Three Months Ended March 31, 2025

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025

SIGA

Aardvark Therapeutics, Inc. - Common Stock

Aardvark Therapeutics

Aurora Cannabis

Alumis

ALT5 Sigma

Aquestive Therapeutics, Inc. - Common Stock

Aquestive Therapeutics

Arvinas

Canopy Growth Corporation - Common Shares

Canopy Growth

Cormedix

Evolus

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics

Eton Pharmaceuticals, Inc. - Common Stock

Eton Pharmaceuticals

Fulcrum Therapeutics, Inc. - Common Stock

Fulcrum Therapeutics

GH Research

High Tide

LB Pharmaceuticals

MBX Biosciences

Mind Medicine (MindMed) Inc. - Common Shares

Mind Medicine

Oculis Holding

Phathom Pharmaceuticals, Inc. - Common Stock

Phathom Pharmaceuticals

Septerna

SNDL

Theravance Biopharma, Inc. - Ordinary Shares

Theravance Biopharma

Terns Pharmaceuticals, Inc. - Common Stock

Comments

SIGA Technologies Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO